1. What is an “Exploitant”? In the French pharmaceutical regulatory system, the Exploitant is the legal entity responsible for placing a medicinal product on the French market. It is the entity recorded on the Marketing Authorization (MA) that ensures the product complies with all regulatory, pharmacovigilance, and distribution obligations in France. 2. Is the exploitant…

Launching a prescription medicine in France requires more than just obtaining marketing authorization. To ensure patients can access your product — and the French health insurance system (Assurance Maladie) covers its cost — you’ll also need to navigate the reimbursement process. Here’s a step-by-step guide to how it works. 📋 Step 1: Obtain Marketing Authorization…

When launching a prescription medicine or medical product in France, one of your first and most important decisions is selecting an exploitant. In the unique French regulatory framework, the exploitant is the legal and regulatory entity responsible for placing the product on the market. They hold the marketing authorization, ensure compliance with ANSM requirements, manage…

France remains one of the most attractive yet challenging pharmaceutical markets in Europe. With a highly regulated environment, price controls, and a centralised reimbursement system, successfully launching and sustaining your product in France requires a solid understanding of the market access landscape — and how it’s evolving in 2026. Why France? France’s single-payer system ensures…

A Comprehensive guide to explore the French MarketUnderstanding the role of Exploitant Introduction The French pharmaceutical market is one of the most complex and highly regulated in Europe, yet it offers substantial opportunities for growth and development. Understanding the local regulatory landscape is essential to ensure successful market entry. A pivotal aspect of this landscape…

Expanding into France can be a lucrative move for pharmaceutical companies, but only if done right. The French healthcare system is unique, highly regulated, and comes with its own set of rules that can catch even seasoned pharma executives off guard. At Elliogen, we specialize in helping pharma companies navigate the complexities of the French…

France has a highly structured and regulated system for distributing medicines. Whether you’re a pharmaceutical company planning to enter the French market or a healthcare professional aiming to navigate the supply chain more efficiently, understanding the different distribution channels and key players is essential. Here’s a clear and up-to-date overview. A Robust and Regulated Infrastructure…

The pharmaceutical landscape is shifting. It’s no longer just about developing groundbreaking therapies; it’s about ensuring those therapies reach the right patients, at the right time, and that those patients are empowered throughout their journey. Traditional methods of patient recruitment and engagement – relying heavily on clinician referrals and broad-stroke awareness campaigns – are often…